drugset / Trial / NCT00257582

Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics

NCT00257582

Phase 3 Completed 60 enrolled GlaxoSmithKline
RandomizedSingle-groupOpen-labelTreatment

Summary

To assess the safety of long-term use of cetirizine dry syrup in children with various type of cutaneous disease accompanied on pruritus.

Timeline

Start
2005-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetirizine Other / unclassified

Indications

No indication recorded.